Large-scale testing (Phase 3)Study completedNCT03837184
What this trial is testing
Single-Dose Gene Replacement Therapy Using for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies
Who this might be right for
Spinal Muscular Atrophy Type I
Novartis Gene Therapies 2